American Healthcare REIT, Inc.
AHRNYSEReal Estate● Active
$46.08
$-1.40(-2.95%)
Market Cap$9.5B
P/E Ratio—
52W High$54.67
52W Low$34.273
American Healthcare REIT, Inc. (AHR) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
AHR · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 7, 2026EPS Actual
$0.13
Est. $0.16 · -19.2%
Revenue
$0.65B
Est. $0.67B · -2.5%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 7, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
AHR reports quarterly as a NYSE-listed REIT - Healthcare Facilities company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 6, 2026 | $0.14 | — | — | — | $0.65B | — |
| ▼ Q2 FY2026 | May 7, 2026 | $0.16 | $0.13 | -19.2% | $0.65B | $0.67B | -2.5% |
| ▼ Q1 FY2026 | Feb 26, 2026 | $0.15 | $0.06 | -61.3% | $0.60B | $0.61B | -0.9% |
| ▼ Q4 FY2025 | Nov 6, 2025 | $0.42 | $0.33 | -21.4% | $0.57B | $0.62B | -6.9% |
| ▼ Q3 FY2025 | Aug 7, 2025 | $0.40 | $0.06 | -85.0% | $0.54B | $0.55B | -1.9% |
| ▼ Q2 FY2025 | May 8, 2025 | $0.37 | -$0.04 | -110.8% | $0.54B | $0.54B | -0.1% |
| ▼ Q1 FY2025 | Feb 27, 2025 | $0.40 | -$0.21 | -152.5% | $0.54B | $0.54B | +0.1% |
| ▼ Q4 FY2024 | Nov 12, 2024 | $0.32 | -$0.03 | -109.4% | $0.52B | $0.47B | +10.4% |
Q3 FY2026
Aug 6, 2026
EPS Actual
—
EPS Est.
$0.14
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 7, 2026Miss
EPS Actual
$0.13
EPS Est.
$0.16
EPS Surpr.
-19.2%
Revenue
$0.65B
Q1 FY2026
Feb 26, 2026Miss
EPS Actual
$0.06
EPS Est.
$0.15
EPS Surpr.
-61.3%
Revenue
$0.60B
Q4 FY2025
Nov 6, 2025Miss
EPS Actual
$0.33
EPS Est.
$0.42
EPS Surpr.
-21.4%
Revenue
$0.57B
Q3 FY2025
Aug 7, 2025Miss
EPS Actual
$0.06
EPS Est.
$0.40
EPS Surpr.
-85.0%
Revenue
$0.54B
Q2 FY2025
May 8, 2025Miss
EPS Actual
-$0.04
EPS Est.
$0.37
EPS Surpr.
-110.8%
Revenue
$0.54B
Q1 FY2025
Feb 27, 2025Miss
EPS Actual
-$0.21
EPS Est.
$0.40
EPS Surpr.
-152.5%
Revenue
$0.54B
Q4 FY2024
Nov 12, 2024Miss
EPS Actual
-$0.03
EPS Est.
$0.32
EPS Surpr.
-109.4%
Revenue
$0.52B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2030 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2030 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2030 | $0.00 | $0.00 | $0.00 | 0 |
| Q1 FY2030 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2029 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2029 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2030 | $0.8B | $0.8B | $0.8B | 1 |
| Q3 FY2030 | $0.8B | $0.8B | $0.8B | 2 |
| Q2 FY2030 | $0.8B | $0.8B | $0.8B | 2 |
| Q1 FY2030 | $0.8B | $0.8B | $0.8B | 1 |
| Q4 FY2029 | $0.7B | $0.8B | $0.8B | 2 |
| Q3 FY2029 | $0.7B | $0.8B | $0.8B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 7, 2026 | -19.2% | $50.02 | $49.60 | -0.84% |
| ▼ Q1 FY2026 | Feb 26, 2026 | -61.3% | $52.92 | $53.19 | +0.51% |
| ▼ Q4 FY2025 | Nov 6, 2025 | -21.4% | $47.09 | $47.92 | +1.76% |
| ▼ Q3 FY2025 | Aug 7, 2025 | -85.0% | $39.65 | $39.86 | +0.53% |
| ▼ Q2 FY2025 | May 8, 2025 | -110.8% | $32.66 | $32.21 | -1.38% |
| ▼ Q1 FY2025 | Feb 27, 2025 | -152.5% | $29.72 | $30.18 | +1.55% |
| ▼ Q4 FY2024 | Nov 12, 2024 | -109.4% | $26.47 | $25.91 | -2.12% |
| ▼ Q3 FY2024 | Aug 5, 2024 | -96.5% | $16.14 | $15.67 | -2.91% |
Q2 FY2026-0.84%
Report Date
May 7, 2026
EPS Beat/Miss
-19.2%
Price Before
$50.02
Price After
$49.60
Q1 FY2026+0.51%
Report Date
Feb 26, 2026
EPS Beat/Miss
-61.3%
Price Before
$52.92
Price After
$53.19
Q4 FY2025+1.76%
Report Date
Nov 6, 2025
EPS Beat/Miss
-21.4%
Price Before
$47.09
Price After
$47.92
Q3 FY2025+0.53%
Report Date
Aug 7, 2025
EPS Beat/Miss
-85.0%
Price Before
$39.65
Price After
$39.86
Q2 FY2025-1.38%
Report Date
May 8, 2025
EPS Beat/Miss
-110.8%
Price Before
$32.66
Price After
$32.21
Q1 FY2025+1.55%
Report Date
Feb 27, 2025
EPS Beat/Miss
-152.5%
Price Before
$29.72
Price After
$30.18
Q4 FY2024-2.12%
Report Date
Nov 12, 2024
EPS Beat/Miss
-109.4%
Price Before
$26.47
Price After
$25.91
Q3 FY2024-2.91%
Report Date
Aug 5, 2024
EPS Beat/Miss
-96.5%
Price Before
$16.14
Price After
$15.67
Avg Miss Reaction-0.36%
Beat Rate0 / 8 quarters
Largest Move-2.91% (Q3 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: AHR ends December
American Healthcare REIT, Inc. (AHR) most recently reported earnings on May 7, 2026 for Q2 FY2026, posting EPS of $0.13 — missing the analyst consensus of $0.16 by -19.2%. The next AHR earnings date is expected around September 1, 2026.
Each quarter, investors track AHR earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. AHR revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
AHR's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
AHR earnings · 5 questionsAmerican Healthcare REIT, Inc.'s next earnings report is expected around September 1, 2026. AHR typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; AHR historically reports after market close (AMC).
AHR earnings datewhen is AHR earningsAHR next earnings datewhen does AHR report earningsAHR earnings calendar
▸ Source: FMP · American Healthcare REIT, Inc. SEC filings · US GAAP · American Healthcare REIT, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026